Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Toledo

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|July 28, 2006
RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analysesFranck Toledo, Chung-Wen Liu, Crystal J Lee, et al.
Disease Models & Mechanisms|September 4, 2023
A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalitiesJeanne Rakotopare, Vincent Lejour, Carla Duval, et al.
Transcription|February 16, 2013
Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoiresAurélie Morin, Boris Bardot, Iva Simeonova, et al.
Plos Genetics|July 5, 2012
Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genesIva Simeonova, Vincent Lejour, Boris Bardot, et al.
Molecular and Cellular Biology|December 13, 2006
Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppressionFranck Toledo, Crystal J Lee, Kurt A Krummel, et al.
NPJ Genomic Medicine|April 18, 2026
Low-penetrance TP53 variants are mainly hypomorphic: an underestimated issue with high clinical significanceLea Rodriguez, Bernard Leroy, Franck Toledo, et al.
Cancer Cell|April 18, 2006
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory networkFranck Toledo, Kurt A Krummel, Crystal J Lee, et al.
Science Advances|April 18, 2020
Germline mutation of <i>MDM4</i>, a major p53 regulator, in a familial syndrome of defective telomere maintenanceEléonore Toufektchan, Vincent Lejour, Romane Durand, et al.
Genes & Development|March 31, 2017
Essential role for centromeric factors following p53 loss and oncogenic transformationDan Filipescu, Monica Naughtin, Katrina Podsypanina, et al.
Elife|April 14, 2025
Oncogenic and teratogenic effects of <i>Trp53</i><sup>Y217C</sup>, an inflammation-prone mouse model of the human hotspot mutant <i>TP53</i><sup>Y220C</sup>Sara Jaber, Eliana Eldawra, Jeanne Rakotopare, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|July 28, 2006
RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analysesFranck Toledo, Chung-Wen Liu, Crystal J Lee, et al.
Disease Models & Mechanisms|September 4, 2023
A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalitiesJeanne Rakotopare, Vincent Lejour, Carla Duval, et al.
Transcription|February 16, 2013
Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoiresAurélie Morin, Boris Bardot, Iva Simeonova, et al.
Plos Genetics|July 5, 2012
Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genesIva Simeonova, Vincent Lejour, Boris Bardot, et al.
Molecular and Cellular Biology|December 13, 2006
Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppressionFranck Toledo, Crystal J Lee, Kurt A Krummel, et al.
NPJ Genomic Medicine|April 18, 2026
Low-penetrance TP53 variants are mainly hypomorphic: an underestimated issue with high clinical significanceLea Rodriguez, Bernard Leroy, Franck Toledo, et al.
Cancer Cell|April 18, 2006
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory networkFranck Toledo, Kurt A Krummel, Crystal J Lee, et al.
Science Advances|April 18, 2020
Germline mutation of <i>MDM4</i>, a major p53 regulator, in a familial syndrome of defective telomere maintenanceEléonore Toufektchan, Vincent Lejour, Romane Durand, et al.
Genes & Development|March 31, 2017
Essential role for centromeric factors following p53 loss and oncogenic transformationDan Filipescu, Monica Naughtin, Katrina Podsypanina, et al.
Elife|April 14, 2025
Oncogenic and teratogenic effects of <i>Trp53</i><sup>Y217C</sup>, an inflammation-prone mouse model of the human hotspot mutant <i>TP53</i><sup>Y220C</sup>Sara Jaber, Eliana Eldawra, Jeanne Rakotopare, et al.
Pageof 3